Latest Loan Facilities News

Brockman Mining Limited continues to develop its Marillana and Ophthalmia iron ore projects through joint ventures, progressing infrastructure plans at Port Hedland while maintaining a modest cash position and strong financing facilities.

Conrad Asia Energy has taken a decisive step from exploration to production with the Final Investment Decision on its Mako Gas Project, booking reserves for the first time and progressing a major farm-down transaction.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.

Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.

Mt Malcolm Mines has delivered a maiden Mineral Resource Estimate of 13,200 ounces across Golden Crown and Dumbarton, while advancing a study on refurbishing a 500,000 tpa CIP plant and preparing for follow-up drilling and funding.

Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.

Parkway Corporate Limited delivered a record $5.21 million quarterly revenue and $0.73 million EBITDA in Q3 FY26, driven by ramp-up of a major water infrastructure project. Meanwhile, its flagship Queensland Brine Management Complex progresses through key development application milestones with public notification underway.

Bellevue Gold Limited surged to record underlying free cash flow of A$158 million in the March 2026 quarter, driven by a 28% jump in ore grades and increased production. The company also advanced exploration with a new high-grade discovery and progressed its $35-40 million paste plant project while maintaining a strong sustainability profile.

Audalia Resources has unveiled a maiden Ore Reserve for its Medcalf vanadium-titanium-iron project alongside an updated Pre-feasibility Study outlining two viable development options with strong economic returns. The company faces a tight cash position but is pursuing a $450,000 capital raise to sustain progress.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.